What are metalloproteins?
Metalloproteins have a protein component and a non-protein metal group that is usually coordinated by amino acid side chains within the protein structure.
The metal acts as a cofactor, enabling or enhancing the protein’s activity. The most common are zinc, iron, and copper metalloproteins. Without the metal ion properly incorporated, the protein would be unable to carry out its biological functions.
Important roles of metalloproteins
Metalloproteins have diverse and critical functions throughout living organisms. Key actions include:
- Enzyme catalysis – Metal ions aid enzymatic reactions for metabolism, DNA synthesis, respiration, and more.
- Oxygen transport and storage – Hemoglobin and myoglobin contain iron to bind oxygen.
- Electron transfer – Cytochromes utilize iron or copper to transport electrons in respiration.
- Structural roles – Zinc fingers help maintain the shape of proteins like DNA transcription factors.
- Hormone regulation – Insulin is stored in the pancreas as a zinc-coordinated hexamer.
- Toxicant defense – Metallothioneins bind heavy metals like cadmium and mercury for detoxification.
Disorders linked to metalloproteins
Defective metalloproteins cause serious disorders by impairing essential biological processes:
– Wilson’s disease – copper accumulation due to transporter dysfunction
– Iron overload disease – excessive iron absorption from hemochromatosis genetic mutations
– Menkes disease – copper deficiency disrupting metabolism
– Aceruloplasminemia – iron buildup resulting from oxidase impairment
Understanding these diseases has elucidated normal and abnormal metalloprotein function. Developing treatments aims to restore healthy metal ion homeostasis.
Matrix metalloproteinases (MMPs) comprise a family of zinc-dependent endopeptidases with important roles in wound healing and tissue remodeling through controlled extracellular matrix protein degradation. Unregulated MMP activity contributes to arthritis, fibrosis, tumor metastasis and other diseases. Over 25 human MMPs have been identified to date.
The major collagen-degrading MMPs are the collagenases, including MMP-1, 8, 13, and 18. Collagenases cleave fibrillar collagens I, II, and III which constitute much of the ECM framework. Collagenases activity facilitates normal Matrix turnover for growth and renewal. Excess collagenolysis leads to pathological matrix destruction in arthritis and injury.
Gelatinases MMP-2 and MMP-9 efficiently digest denatured collagen fragments (gelatin). They also cleave basement membrane collagen IV and other ECM components. Gelatinase upregulation is implicated in cancer progression and chronic inflammatory conditions.
Besides the collagenases and gelatinases, MMPs that target other ECM proteins have been identified. These include MMPs 3, 7, 10, 11, 12, 19, 20, 26, and 28. Each has distinct substrate preferences, localization, and regulation. Together the MMP family can degrade all ECM constituents.
Studying and imaging metalloproteins
Researchers employ an array of techniques to study metalloprotein structure and characterize their functions:
- X-ray crystallography reveals 3D protein structure including the metal binding sites. Spectroscopic methods like NMR, EPR, and UV-Vis examine the metal center and its properties within the protein environment. Mass spectrometry identifies metalloprotein composition.
- Metalloprotein interactions can be analyzed through affinity chromatography and pull-down assays. Cell culture and animal models show effects in living systems. Genetic mutations help determine functional mechanisms.
- Advanced microscopy visualizes metalloproteins in cells using probes that bind and fluoresce at the metal centers.
- In vivo medical imaging is also developing metalloprotein-targeted approaches. For example, MMP-targeted optical probes activated by enzyme activity provide real-time imaging of cancer metastases. MRI contrast agents are in development that would signal the presence of certain metalloproteins.
- Real-time, continuous hormone monitoring could improve management for diabetes and other conditions compared to periodic snapshots with current biomarkers. Nanotechnology and implantable sensors may make this possible.
Related ELISA Kits
Matrix Matalloproteinse ELISA Kits:
Online Enquiry Form
"*" indicates required fields